Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value per share (DNTH)

98 filings reported holding DNTH - Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value per share as of Q3 2024.
Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value per share (DNTH) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 31.4M shares of 32.3M outstanding shares and own 97.23% of the company stock.
Largest 10 shareholders include FMR LLC (4.4M shares), Bain Capital Life Sciences Investors, LLC (3.01M shares), Avidity Partners Management LP (2.92M shares), Fairmount Funds Management LLC (2.7M shares), RA CAPITAL MANAGEMENT, L.P. (2.33M shares), Octagon Capital Advisors LP (1.75M shares), VR Adviser, LLC (1.74M shares), BlackRock, Inc. (1.64M shares), VANGUARD GROUP INC (1.29M shares), and 5AM Venture Management, LLC (1.23M shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.